DocDollars

Beone Medicines Ltd.

Switzerland · Reporting entity ID 100001453393

Total reported 2019–2025
$47.5M
#182 of 2,960 reporting companies — 0.1% of all reported industry payments
$137K in general payments across 13 records, plus $47.1M in research funding across 2,826 records.

How it breaks down

General payments $136,724
Research funding $47,148,548
Ownership & investment $197,173

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Beone Medicines Ltd. reported $47.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #182 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 13 general payment records and 2,826 research records were filed.

Common questions about Beone Medicines Ltd.

How much has Beone Medicines Ltd. paid US doctors?

Beone Medicines Ltd. reported $47,482,445 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $136,724 in general payments, $47,148,548 in research funding and $197,173 in ownership and investment interests.

How does Beone Medicines Ltd. rank among drug and device companies?

It ranks #182 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Beone Medicines Ltd. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.